Biomarkers and Cardiac CT

Coronary artery disease (CAD) is the leading cause of morbidity and mortality in developed countries. In addition, many patients suffer from valvular and aortic disease. Although various tools are available to identify patients with cardiovascular (CV) disease at risk for major adverse cardiac events (MACE), the identification of these patients remains a clinical challenge. One promising avenue is the use of different serum biomarkers involved in atherothrombosis which could provide an easy and cost-effective step in risk stratification.

NCT Number	NCT02381301
Lead Sponsor	Maastricht University Medical Center
Conditions	Coronary Artery Disease, Atherosclerosis
Enrollment	5,000 participants
Start Date	2015-02
Primary Completion	2029-12 (estimated)
Study Completion	2029-12 (estimated)
Updated on ClinicalTrials.gov	2017-03-28